Generex Announces Featured Presentation of Cancer Immunotherapy Developed by Subsidiary at OPT Boston – Business Wire (press release)
|
Generex Announces Featured Presentation of Cancer Immunotherapy Developed by Subsidiary at OPT Boston
Business Wire (press release) Dr. von Hofe’s Featured Presentation, Advantages of a Peptide-Based Vaccine Designed to Activate CD4+ T Cells in Cancer Immunotherapy, is scheduled for 8:30 am EDT on Wednesday, March 29 as part of the Peptides in Cancer Therapy symposium. |
Daily Mail |
Stem cells shown to restore erection capability in men with erectile dysfunction
Science Daily New clinical trial results show that stem cells can restore sufficient erectile function to allow previously impotent men to have spontaneous intercourse. This is the first time stem cell therapy has produced patients who have recovered sufficient … Just ONE injection of stem cells from a man’s stomach could be a permanent cure for impotence (and even help them to …Daily Mail Health Highlights: March 27, 2017HealthDay |
|
APEIRON Biologics Receives Green Light for Marketing Approval of a Neuroblastoma Immunotherapy in the European …
PR Newswire (press release) Dr. Hans Loibner, Apeiron’s Chief Executive Officer, said, “We are delighted with the CHMP positive opinion for approval of dinutuximab beta for immunotherapy of high risk neuroblastoma, an area of significant unmet medical need. We regard this as key … |
Daily Mail |
Just ONE injection of stem cells from a man’s stomach could be a permanent cure for impotence (and even help them to …
Daily Mail A single injection of stem cells could be a long-lasting cure for impotency, scientists have announced. Results from a trial of men with severe erectile dysfunction shows the stem cell therapy effectively restores spontaneous sexual function. The … Health Highlights: March 27, 2017HealthDay |
|
Patient advocacy experts gather to start a conversation on cancer immunotherapy in Canada
Yahoo Finance “Cancer immunotherapy medicines have been one of the greatest advancements in cancer treatment, allowing patients with metastatic and advanced disease a real chance of survival, and I am living proof of this reality,” says Kathy Barnard, Founder and … |